Oct 11, 2026 11:42AM
Oct 11, 2026 11:42AM
Oct 7, 2026 06:48AM
Oct 7, 2026 06:45AM
Oct 6, 2026 07:30AM
Oct 6, 2026 07:30AM
Oct 6, 2026 06:54AM H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
Oct 5, 2026 12:21PM
Oct 5, 2026 10:43AM
Oct 5, 2026 07:31AM
Oct 5, 2026 07:30AM
Aug 31, 2026 01:59PM
Aug 12, 2026 06:54AM
Aug 11, 2026 09:54AM BridgeBio Pharma (BBIO) PT Raised to $115 at Piper Sandler as 'Attruby Outperforms'
Aug 10, 2026 04:01PM
Jul 24, 2026 07:26AM
Jul 22, 2026 07:31AM
Jul 22, 2026 07:30AM
Jun 16, 2026 06:42AM
May 27, 2026 07:30AM
May 27, 2026 07:30AM BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9
May 7, 2026 04:01PM
Mar 30, 2026 09:50AM
Feb 15, 2025 10:00PM
Dec 18, 2024 09:08AM
Nov 25, 2024 08:24AM
Nov 25, 2024 08:12AM
Nov 18, 2024 11:15AM Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
Nov 12, 2024 07:30AM
Sep 30, 2024 08:25AM
Sep 27, 2024 06:00PM
Sep 11, 2024 07:40AM
Aug 30, 2024 10:50AM
Aug 30, 2024 10:50AM
Aug 2, 2024 12:19PM BridgeBio Pharma (BBIO) PT Lowered to $45 at Citi
Aug 1, 2024 07:30AM
Jun 24, 2024 11:36AM
May 30, 2024 05:39AM
May 29, 2024 04:01PM
May 13, 2024 07:30AM
May 13, 2024 07:30AM
May 2, 2024 07:30AM BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
Apr 7, 2024 01:15PM
Mar 4, 2024 02:30AM
Feb 23, 2024 12:35PM
Feb 22, 2024 07:30AM
Feb 5, 2024 07:32AM
Feb 5, 2024 07:30AM
Jan 31, 2024 03:46AM BMO Capital Starts BridgeBio Pharma (BBIO) at Market Perform, 'Two Promising Products but Success Largely Priced In'
Jan 6, 2020 07:31AM

15,963 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All